Clinical Trial Update: Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating an SGLT-2 inhibitor for managing postoperative hyperglycemia in patients following acute abdominal surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Hyperglycemia
• Stress Hyperglycemia

Drugs mentioned

• SGLT-2 inhibitor

Snippet

Sponsor: Zealand University Hospital | Conditions: Postoperative Hyperglycemia, Stress Hyperglycemia | Phase 2 | Status: UNKNOWN